Experienced in IgG4-Related Disease

Dr. Sujatha Nallapareddy

Hematology
Rocky Mountain Cancer Centers
Rocky Mountain Cancer Centers Llp
10103 Ridgegate Pkwy, G01, 
Lone Tree, CO 
Offers Telehealth

Experienced in IgG4-Related Disease
Rocky Mountain Cancer Centers
Rocky Mountain Cancer Centers Llp
10103 Ridgegate Pkwy, G01, 
Lone Tree, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Sujatha Nallapareddy is a Hematologist in Lone Tree, Colorado. Dr. Nallapareddy is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Iron Deficiency Anemia.

Her clinical research consists of co-authoring 3 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology
Licenses
Internal Medicine in CO
Hospital Affiliations
The Medical Center Of Aurora & South Hospital
Littleton Adventist Hospital, Centura Health
Kit Carson County Memorial Hospital
Lincoln Health Hospital
Hca-Healthone Dba Swedish Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

ROCKY MOUNTAIN CANCER CENTERS LLP
10103 Ridgegate Pkwy, G01, Lone Tree, CO 80124
Call: 303-925-0700
Other Locations
ROCKY MOUNTAIN CANCER CENTERS LLP
1800 Williams St, Suite 200, Denver, CO 80218
Call: 303-388-4876
ROCKY MOUNTAIN CANCER CENTERS LLP
11750 W 2nd Place, Suite 150, Lakewood, CO 80228
Call: 303-763-4020
ROCKY MOUNTAIN CANCER CENTERS LLP
22 W Dry Creek Circle, Littleton, CO 80120
Call: 303-730-4700
ROCKY MOUNTAIN CANCER CENTERS LLP
8820 Huron St, Thornton, CO 80260
Call: 303-386-7622
ROCKY MOUNTAIN CANCER CENTERS LLP
3027 N Circle Dr, Colorado Springs, CO 80909
Call: 719-577-2555

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: Fruquintinib
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-controlled, Active Comparator Phase 2/3 Study of Tucatinib in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Subjects With Previously Treated, Locally-advanced Unresectable or Metastatic HER2+ Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)
A Randomized, Double-blind, Placebo-controlled, Active Comparator Phase 2/3 Study of Tucatinib in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Subjects With Previously Treated, Locally-advanced Unresectable or Metastatic HER2+ Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)
Enrollment Status: Completed
Publish Date: January 22, 2025
Intervention Type: Drug, Other
Study Drugs: Tucatinib, Trastuzumab, Ramucirumab, Paclitaxel
Study Phase: Phase 2/Phase 3
MOUNTAINEER: A Phase II, Open Label Study of Tucatinib Combined With Trastuzumab in Patients With HER2+ Metastatic Colorectal Cancer
MOUNTAINEER: A Phase II, Open Label Study of Tucatinib Combined With Trastuzumab in Patients With HER2+ Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: November 26, 2024
Intervention Type: Drug
Study Phase: Phase 2
Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Randomized Study of AM0010 in Combination With FOLFOX Compared to FOLFOX Alone as Second-line Tx in Pts With Metastatic Pancreatic Cancer That Has Progressed During or Following a First-Line Gemcitabine Containing Regimen
Enrollment Status: Completed
Publish Date: October 19, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

3 Total Publications

Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
Journal: The Lancet. Oncology
Published: July 19, 2012
View All 3 Publications
Similar Doctors
Experienced in IgG4-Related Disease
Dr. Christopher Benton
Hematology
Experienced in IgG4-Related Disease
Dr. Christopher Benton
Hematology

Rocky Mountain Cancer Centers Llp

1700 S Potomac St, 
Aurora, CO 
 (11.0 miles away)
303-418-7600
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Christopher Benton is a Hematologist in Aurora, Colorado. Dr. Benton is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Myeloproliferative Neoplasms (MPN), and Bone Marrow Aspiration.

Experienced in IgG4-Related Disease
Dr. Jeffrey T. Owsley
Oncology | Hematology Oncology | Hematology
Experienced in IgG4-Related Disease
Dr. Jeffrey T. Owsley
Oncology | Hematology Oncology | Hematology

Lutheran Hospital - Cancer Centers Of CO Medical Oncology

400 Indiana Street, Suite 300, 
Golden, CO 
 (20.4 miles away)
303-403-7333
Experience:
17+ years
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Born in Kansas City, Missouri, Dr. Owsley earned his medical degree in Kansas City. He moved to Denver and completed his residency at Saint Joseph Hospital. After his residency, he worked as a hospitalist in Denver prior to starting a fellowship at the University of Tennessee in Memphis. His clinical interests surround melanoma, lymphoma and primary brain cancers.�A cancer diagnosis is an ailment that encompasses the entire person and as an oncologist, I am privileged to be a part of my patient�s journey. We would not just focus on the disease itself, but also on the effect it has on other aspects of the patient�s life. Overriding everything, we must never lose hope.�Dr. Owsley makes it a priority to be with his patients every step of the way during their cancer journey. He will fight alongside them and is readily available to assist in each patient�s unique journey.Dr. Owsley is an investigator involved in clinical research trials in the area of hematology and medical oncology.�When not at work, Dr. Owsley spends his time watching his daughter grow up. He enjoys watching sports and rooting for his favorite teams including the Kansas City Chiefs. However, his wife is a native Denverite and makes sure to balance out his love of the Chiefs with her love of the Broncos. He loves taking advantage of the amazing opportunities that the 300 days of Colorado sunshine provide. Dr. Owsley is rated as an Experienced provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Paget Disease of the Breast, Breast Cancer, Lynch Syndrome, and Squamous Cell Lung Carcinoma.

Experienced in IgG4-Related Disease
Dr. Mark A. Sitarik
Hematology Oncology | Hematology | Oncology
Experienced in IgG4-Related Disease
Dr. Mark A. Sitarik
Hematology Oncology | Hematology | Oncology

Rocky Mountain Cancer Centers Llp

4715 Arapahoe Ave, 
Boulder, CO 
 (38.7 miles away)
303-385-2000
Experience:
44+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Sitarik is a Hematologist Oncology specialist and a Hematologist in Boulder, Colorado. Dr. Sitarik has been practicing medicine for over 44 years and is rated as a Distinguished provider by MediFind in the treatment of IgG4-Related Disease. His top areas of expertise are Heyde Syndrome, Von Willebrand Disease (VWD), Paget Disease of the Breast, and Breast Cancer.

VIEW MORE IGG4-RELATED DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Nallapareddy's expertise for a condition
ConditionClose
    • Distinguished
    • Breast Cancer
      Dr. Nallapareddy is
      Distinguished
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Childhood Iron Deficiency Anemia
      Dr. Nallapareddy is
      Distinguished
      . Learn about Childhood Iron Deficiency Anemia.
      See more Childhood Iron Deficiency Anemia experts
    • Colorectal Cancer
      Dr. Nallapareddy is
      Distinguished
      . Learn about Colorectal Cancer.
      See more Colorectal Cancer experts
    • Deep Vein Thrombosis
      Dr. Nallapareddy is
      Distinguished
      . Learn about Deep Vein Thrombosis.
      See more Deep Vein Thrombosis experts
    • Familial Colorectal Cancer
      Dr. Nallapareddy is
      Distinguished
      . Learn about Familial Colorectal Cancer.
      See more Familial Colorectal Cancer experts
    • Familial Pancreatic Cancer
      Dr. Nallapareddy is
      Distinguished
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    View All 17 Distinguished Conditions
    • Advanced
    • Acute Mountain Sickness
      Dr. Nallapareddy is
      Advanced
      . Learn about Acute Mountain Sickness.
      See more Acute Mountain Sickness experts
    • Adult Immune Thrombocytopenia
      Dr. Nallapareddy is
      Advanced
      . Learn about Adult Immune Thrombocytopenia.
      See more Adult Immune Thrombocytopenia experts
    • Adult Soft Tissue Sarcoma
      Dr. Nallapareddy is
      Advanced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Agranulocytosis
      Dr. Nallapareddy is
      Advanced
      . Learn about Agranulocytosis.
      See more Agranulocytosis experts
    • Alveolar Soft Part Sarcoma
      Dr. Nallapareddy is
      Advanced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Anal Cancer
      Dr. Nallapareddy is
      Advanced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    View All 76 Advanced Conditions
    • Experienced
    • Acquired Agranulocytosis
      Dr. Nallapareddy is
      Experienced
      . Learn about Acquired Agranulocytosis.
      See more Acquired Agranulocytosis experts
    • Acute Arterial Occlusion of Kidney
      Dr. Nallapareddy is
      Experienced
      . Learn about Acute Arterial Occlusion of Kidney.
      See more Acute Arterial Occlusion of Kidney experts
    • Acute Hepatic Porphyria (AHP)
      Dr. Nallapareddy is
      Experienced
      . Learn about Acute Hepatic Porphyria (AHP).
      See more Acute Hepatic Porphyria (AHP) experts
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Nallapareddy is
      Experienced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Nallapareddy is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Nallapareddy is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    View All 188 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved